Finzati - Logo
PULM logo

Pulmatrix, Inc.

PULM • Biotechnology
$1.43
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$5.22M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 12.55Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:39 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.43
Change0.00%
Shares Out3.65M
Market Cap$5.22M
Enterprise Value$3.05M
52W Range1.16 - 5.50
Beta1.90
P/E-1.30
P/B2.04
P/FCF-1.34
EV/EBITDA-0.74
EV/FCF-0.78

Investment DNA

How strong this company looks for long-term investors

40
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
86/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 12.55Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

PULM
Analyst sentiment
Based on 1 analyst votes · 2026-10-20
100/100
Bullish
Bullish
1
Hold
0
Bearish
0

Company Overview

IPO: 3/21/2014
Industry: Biotechnology
P/B i: 2.04
Debt / Equity i: 0.00
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.00
Current Ratio: 12.55
Quick Ratio: 12.55
Status: Good

Insider Transactions

Recent executive and insider activity

Batycky Richard P.
Transaction: 01/26/2023
BUY
Change
+1,700
Price
Not reported
Filing
01/30/2023
Type
BUY
Varadan Anand
Transaction: 01/26/2023
BUY
Change
+1,700
Price
Not reported
Filing
01/30/2023
Type
BUY
Cabell Christopher
Transaction: 01/26/2023
BUY
Change
+1,700
Price
Not reported
Filing
01/30/2023
Type
BUY